help information
46.6 ° F
Full Weather

Asterias Biotherapeutics 3Q Earnings Snapshot

FREMONT, Calif. _ Asterias Biotherapeutics Inc. (AST) on Friday reported a loss of $4.5 million in its third quarter.

The Fremont, California-based company said it had a loss of 8 cents per share.

The stem cell therapy developer posted revenue of $116,000 in the period.

In the final minutes of trading on Friday, the company’s shares hit $1.30. A year ago, they were trading at $2.45.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AST at https://www.zacks.com/ap/AST